ArticleFrontiers in microbiology2017
Biocontrol of Bacterial Leaf Blight of Rice and Profiling of Secondary Metabolites Produced by Rhizospheric
Article in Frontiers in microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
75 citing papers in PubMed, 228 citations in OpenAlex.
- Bacteriophages in the Rhizosphere: Roles in Nutrient Cycling, Bacterial Community Structure, and Animal-Mediated Dispersal.MicrobiologyOpen · 2026Review
- Review
- Integrated metabolomics and bioactivity analysis ofFrontiers in genetics · 2026Article
- Unlocking the potential ofFrontiers in microbiology · 2026Article
- Dynamics of rice microbiome: insights into functional diversity, environmental influences, response to stress, and applications.World journal of microbiology & biotechnology · 2025Review
- Biotic Stress Alleviation in Plant Using Rhizobacteria: An Overview of Mechanism of Action, Antimicrobial Compounds Production, (Nano) Formulations and Employment Methods.Indian journal of microbiology · 2025Review
- Manganese Nanomaterials: A Green Solution to SuppressPlants (Basel, Switzerland) · 2025Article
- Biocontrol and Growth Promotion of Rice byJournal of microbiology and biotechnology · 2025Article
- Review
- Microbiome Engineering for Sustainable Rice Production: Strategies for Biofertilization, Stress Tolerance, and Climate Resilience.Microorganisms · 2025Review
- Evaluating Xanthomonas oryzae pv. oryzae (Xoo) infection dynamics in rice for distribution routes and environmental reservoirs by molecular approaches.Scientific reports · 2025Article
- Biocontrol efficacy ofPeerJ · 2025Article
- Metabolic modeling of host-microbe interactions.Computational and structural biotechnology journal · 2025Review
- Genomic, LC-MS, and FTIR Analysis of Plant Probiotic Potential of Bacillus albus for Managing Xanthomonas oryzae via Different Modes of Application in Rice (Oryza sativa L.).Probiotics and antimicrobial proteins · 2024Article
- Progress in the Study of Natural Antimicrobial Active Substances inMolecules (Basel, Switzerland) · 2024Review
- Mechanism of Rice Resistance to Bacterial Leaf Blight via Phytohormones.Plants (Basel, Switzerland) · 2024Review
- Review
- Green synthesis of chitosan nanoparticles using tea extract and its antimicrobial activity against economically important phytopathogens of rice.Scientific reports · 2024Article
- Shared governance in the plant holobiont and implications for one health.FEMS microbiology ecology · 2024Article
- Marker-assisted breeding accelerates the development of multiple-stress-tolerant rice genotypes adapted to wider environments.Frontiers in plant science · 2024Article
15 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.